{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:32:39Z","timestamp":1790872359820,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,17]]},"DOI":"10.1097\/qad.0b013e328354b419","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T09:43:54Z","timestamp":1335519834000},"page":"1363-1370","source":"Crossref","is-referenced-by-count":78,"title":["A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis"],"prefix":"10.1097","volume":"26","author":[{"given":"Arthur T.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Phulusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Namarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chikasema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Creto","family":"Kanyemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina C.","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa065711","article-title":"Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.","volume":"357","author":"Scarborough","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients.","volume":"14","author":"Hakim","year":"2000","journal-title":"AIDS"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases.","volume":"10","author":"Jarvis","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ije\/27.4.698","article-title":"Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.","volume":"27","author":"Okongo","year":"1998","journal-title":"Int J Epidemiol"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.","volume":"23","author":"Jarvis","year":"2009","journal-title":"AIDS"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIVAIDS.","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.01188-06","article-title":"Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis.","volume":"51","author":"Brouwer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13693780701851695","article-title":"Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.","volume":"46","author":"Milefchik","year":"2008","journal-title":"Med Mycol"},{"key":"R23-6-20210130","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.42.3.528","article-title":"Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.","volume":"42","author":"Diamond","year":"1998","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328354b419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:33:29Z","timestamp":1620970409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201207170-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,17]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328354b419","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,17]]}}}